FDA Inspection 1031233 — Hospira, Inc.

Hospira, Inc. — FEI 1925262

The FDA completed an inspection of Hospira, Inc. on October 27, 2017 in Mcpherson, KS. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 27, 2017
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mcpherson, KS (United States)